An update: government approaches to HPV vaccination
By Josh McNamara | November 9, 2011A panel at the Centers for Disease Control and Prevention voted unanimously last month to recommend routine vaccination of boys against human papillomavirus, the most prevalent sexually transmitted virus in the United States and the cause of nearly all cases of cervical cancer. In 2006, the Food and Drug Administration approved Merck's Gardasil vaccine for females aged 9 to 26, and in 2009 the vaccine was approved for males in the same age range.
